Ticker LaunchReverse merger · Completed
MySpray Therapeutics Inc.
Reverse merger with Adorbs Inc.
MySpray Therapeutics Inc. merged into Adorbs Inc., a shell company run by custodian David Lazar, in a reverse merger that takes the private company public. The agreement was signed and the deal closed on the same day, Feb 10, 2022. The combined company trades as Adorbs Inc. (later Soul Biotechnology Corp).
- Status
- Completed
- Private company
- MySpray Therapeutics Inc.
- Public company
- Adorbs Inc.
- Public company business before
- shell company run by custodian David Lazar
- Announced
- Signed and closed the same day
- Closed
- Feb 10, 2022
- Combined company
- Adorbs Inc. (later Soul Biotechnology Corp)
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Feb 10, 2022
- All filings on EDGAR CIK 1726822
Other completed reverse mergers
- Bitech Mining Corporationinto Spine Injury Solutions, Inc. · Mar 31, 2022
- Pineapple Energy LLCinto Communications Systems, Inc. · Mar 28, 2022
- Karbon-X Project, Inc.into Cocoluv, Inc. · Mar 21, 2022
- DriveItAway, Inc.into Creative Learning Corporation · Feb 24, 2022
- Instadose Pharma Corp. (British Columbia)into Mikrocoze Inc. (renamed Instadose Pharma Corp.) · Dec 31, 2021
- Tengjunxiang Biotechnology Ltd.into China Herb Group Holdings Corp · Dec 23, 2021